KN

Kuniamuthur Nanjappan Anand

Active Director Director DIN 03230186
DIN 03230186 First appointment Nov 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 6 historical roles
Total affiliations 8 Since Nov 2010
Shareholding value •••• Premium profile

About Kuniamuthur Nanjappan Anand

Data last updated:

Kuniamuthur Nanjappan Anand is a Director at Kabra Drugs Limited (since 2022) and Director at Drushya Entertainment Broadcast Streams Limited (since 2015). The companies operate in Pharma, Internet and Information Technology. The largest current company by reported revenue is Kabra Drugs Limited at ₹64 Lakh (FY 2025). Earlier, Kuniamuthur Nanjappan Anand was an Additional Director at Nexgen Animators Private Limited (2018–2023) and Director at Agrata Biotech Limited (2010–2021) and 4 more.

DIN 03230186
Primary Designation Director
Industry Pharma
First Appointment 15 Nov 2010
Oldest Company Age 37 yrs
Largest company Kabra Drugs Limited · ₹64 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kabra Drugs Limited L02423MP1989PLC005438
Director09 Jun 20221989₹64 Lakh (FY 2025)Active
Director02 Feb 20152004Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nexgen Animators Private Limited U72900TN2006PTC060302
Additional Director23 Feb 20182006Active
Agrata Biotech Limited U74999TN2009PLC071298
Director15 Nov 20102009₹17 Lakh (FY 2020)Active
Verna Softech Limited U30006TN1999PLC043363
Director31 Dec 20201999₹66.4 Lakh (FY 2020)Active
Designated Partner26 Oct 20162016Strike Off
Director20 Oct 20112010Strike Off
Thulasi Med Life Private Limited U85190TN2019PTC126740
Director07 Jan 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Kuniamuthur Nanjappan Anand

Directorship timeline

Open interactive timeline →
Zolalife Sciences Llp
Drushya Entertainment Broadcast Streams Limited
Agrata Corporate Solutions Private Limited
Thulasi Med Life Private Limited
Premium access

Shareholding and investment profile for Kuniamuthur Nanjappan Anand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kuniamuthur Nanjappan Anand

Kuniamuthur Nanjappan Anand currently holds 2 directorships: Kabra Drugs Limited (Director, since 09 Jun 2022, revenue ₹64 Lakh (FY 2025)); Drushya Entertainment Broadcast Streams Limited (Director, since 02 Feb 2015).

Kuniamuthur Nanjappan Anand was first appointed on 15 Nov 2010 as Director at Agrata Biotech Limited. The most recent appointment on record is 09 Jun 2022 at Kabra Drugs Limited.

Kuniamuthur Nanjappan Anand held 6 earlier board appointments: Nexgen Animators Private Limited (Additional Director, 23 Feb 2018 to 31 Aug 2023); Agrata Biotech Limited (Director, 15 Nov 2010 to 15 Mar 2021); Verna Softech Limited (Director, 31 Dec 2020 to 15 Mar 2021); Zolalife Sciences Llp (Designated Partner, from 26 Oct 2016); Agrata Corporate Solutions Private Limited (Director, from 20 Oct 2011); and 1 more.

The current boards of Kuniamuthur Nanjappan Anand's companies include Anand Anitha (Kabra Drugs Limited), Monam Kapoor (Kabra Drugs Limited), Monika Nishant Gattani (Kabra Drugs Limited), Nanjappan Aravind (Kabra Drugs Limited), Nikita Sinha (Kabra Drugs Limited), Pavanasam (Kabra Drugs Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available